Mitochondria and chloroplasts are essential organelles driving energy
production and metabolism in eukaryotic cells. Mitochondria, known as the cell’s
“powerhouses,” generate ATP through oxidative phosphorylation, utilizing nutrients to
fuel cellular processes. According to the endosymbiotic theory, mitochondria
originated from free-living bacteria, and their distinct mitochondrial DNA (mtDNA) is
maternally inherited. Dysfunction in mitochondria—often due to accumulation of
mtDNA mutations—is associated with neurodegenerative diseases, metabolic
syndromes, and cancer, with recent studies revealing their roles in aging and disease.
These insights are advancing therapies to improve mitochondrial health, and genome
editing now holds the potential for correcting pathogenic mtDNA mutations.
Chloroplasts in plant cells are essential for photosynthesis, synthesizing carbohydrates,
amino acids, fatty acids, and membrane lipids. Chloroplasts are sensitive to
temperature stress, and their malfunction can produce Reactive Oxygen Species (ROS),
which may be fatal to plant cells. This sensitivity makes chloroplast health crucial for
plant resilience, especially under climate stress. Future research in mitochondrial and
chloroplast should concentrate on offering potential treatments for human diseases and
developing stress-resistant crops. Genome editing technologies could address
mitochondrial and chloroplast dysfunction, creating innovative therapies and
sustainable agricultural practices to address health and environmental challenges.
Keywords: Cellular Respiration, Endosymbiotic Theory, Energy Production, Electron Transport Chain, Krebs Cycle, Mitochondria-Associated Membranes (MAMs), Mitochondrial DNA (mtDNA), Oxidative Phosphorylation, Reactive Oxygen Species (ROS), Uniparental Inheritance.
